Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronobiology-guided variable colchicine dosing in colchicine-nonresponsive familial Mediterranean fever
MOH_2022-04-03_010634Phase 2Not yet recruiting
- Sponsor
- ד"ר פאדי כרוף
- Start
- Jan 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of colchicine in Familial Mediterranean fever (FMF), sponsored by ד"ר פאדי כרוף. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
colchicine
03
Conditions
Familial Mediterranean fever (FMF)
Beyond the preview
Go deeper on MOH_2022-04-03_010634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2022-04-03_010634.